BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will participate on a panel to discuss exit strategies, the growing role of Pharma venture capital and alternative financing strategies at the 8th annual BioExec Institute Retreat on Friday, March 23 in Miami, Florida.
News | 03. 19. 2012
Art Pappas will participate on a panel to discuss exit strategies, the growing role of Pharma venture capital and alternative financing strategies at the 8th annual BioExec Institute Retreat on Friday, March 23 in Miami, Florida.
